Schizophrenia articles & resources on Made-in-China.com

Rayvio and Boston University Expand UV LED Research to Combat Vitamin D Deficiency Disorders

Aug 1, 2016

Health and hygiene company RayVio Corp of Haywood, CA, USA, which is commercializing deep-ultraviolet (UV) LEDs and consumer disinfection solutions, is expanding a research program with Boston University to develop new treatments for ...

Tags: UV LEDs, UV light

Argentina's Next Energy Minister Aims to Lure Fresh Investment

Dec 2, 2015

Juan Jose Aranguren, the next energy minister of Argentina, said Friday he will seek to rebuild investor confidence in the country by improving business conditions after taking office December 10. "We need, as in other sectors of economic ...

Tags: crude, diesel, gas

Potential Breakthrough Drug Might Come From Big Tobacco

Aug 1, 2014

Big Tobacco, almost unbelievably, is lending a hand in the creation of a potential breakthrough drug, a new class of drugs that could dull grave psychiatric disorders, improve attention of ADHD afflicted children, repel Alzheimer's onset, ...

Tags: Agriculture, Tobacco, Ecigarette

The Electronic Cigarette's Future

Jun 13, 2014

President of the Spanish Society of Pathology double Supervisor (EDPS), Dr. Nestor Szerman defended Wednesday by inhaling nicotine electronic cigarette as "effective treatment" for these patients because they help to counteract the side ...

Tags: electronic cigarette, e cigarette, e-cigarette

Verbal Memory Appears to Be a Predictor of Clinical Remission in Patients

Mar 4, 2014

Verbal memory appears to be a predictor of clinical remission in patients with first-episode psychosis, according to Canadian researchers writing in Schizophrenia Research. Martin Lepage (Douglas Mental Health University Institute, ...

Tags: Psychosis, Verbal Memory, Health&Medicine

Psychosis Patients Were More Likely Than Others to Disengage Intervention Program

Feb 27, 2014

By Afsaneh Gray, medwireNews Reporter A study of first-episode psychosis patients in Hong Kong has found that those with fewer negative symptoms at presentation and poor medication compliance were more likely than others to disengage from ...

Tags: Intervention, Disengagement, negative symptom, schizoaffective disorder

Psychosis Patients Were More Likely to Disengage From an Early Intervention Program

Feb 27, 2014

By Afsaneh Gray, medwireNews Reporter A study of first-episode psychosis patients in Hong Kong has found that those with fewer negative symptoms at presentation and poor medication compliance were more likely than others to disengage from ...

Tags: Intervention, Disengagement, negative symptom, schizoaffective disorder

Findings Suggest Similar Origins of Some Cases of Schizophrenia and Autism in Humans

Feb 26, 2014

Findings suggest similar origins of some cases of schizophrenia and autism in humans Johns Hopkins researchers report that fetal mice — especially males — show signs of brain damage that lasts into their adulthood when they ...

Tags: Immune Response, Prenatal Exposure, journal Brain, maternal infection

More Seniority Employees Had on Job,More Positively They Viewed People with Mental Illness

Feb 14, 2014

One might think that after years of seeing people at their worst, mental health workers would harbor negative attitudes about mental illness, perhaps associating people with mental health issues as less competent or dangerous. But a new ...

Tags: mental health, mental illness

Women Are Nearly Twice as Likely to Experience Pre-Eclampsia Complications

Feb 14, 2014

Women with schizophrenia are nearly twice as likely to experience pre-eclampsia, pre-term birth and other serious pregnancy and delivery complications as women without the condition, a landmark study by researchers at the Institute for ...

Tags: Health&Medicine

Omeros Corporation Announced Positive Results From a Phase 2A Clinical Trial of OMS824

Feb 7, 2014

Omeros Corporation (NASDAQ: OMER) today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic ...

Tags: NASDAQ, PDE, PET, OM824

Levels of Glutamine Are Elevated in The Dorsal Anterior Cingulate of Patients

Jan 15, 2014

By Eleanor McDermid, Senior medwireNews Reporter Levels of glutamine, but not glutamate, are elevated in the dorsal anterior cingulate of patients with established schizophrenia, say researchers. Most previous studies have measured ...

Tags: Health, Medicine

Psychoeducation Should Be Routinely Offered to Family Members of Schizophrenia Patients

Jan 10, 2014

Psychoeducation should be routinely offered to family members of schizophrenia patients as early as possible following diagnosis, findings from a mixed-method systematic review indicate. The results, based on quantitative and qualitative ...

Tags: Health, Medicine

Extending Treatment with The Smoking Cessation Drug Chantix May Help Them Avoid a Relapse

Jan 9, 2014

For people with serious mental illness who are trying to quit smoking, extending their treatment with the smoking cessation drug Chantix (varenicline) may help them avoid a relapse, according to a new study. After a standard 12-week ...

Tags: mental illness, quit smoking, Chantix, avoid relapse

DE Is Significantly Correlated with an Array of Cognitive Functions

Jan 6, 2014

By Joanna Lyford, Senior medwireNews Reporter Diminished expression (DE), a core negative symptom in people with schizophrenia, is significantly correlated with an array of cognitive functions, research by a Hong Kong team shows. ...

Tags: diminished expression, negative symptom, schizophrenia

Schizophrenia

Related Products